. 2023 Feb 10;28(4):341–350. doi: 10.1093/oncolo/oyac251
© The Author(s) 2023. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 3.
Overall survival (OS) NAFLD/NASH vs other etiologies cohorts.